Ge Healthcare Techs (GEHC) closed at $82.38 on November 6, 2026, down 1.6% from the previous close, on volume of 3,782,547 shares (30-day average 3,981,155).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 12, 2026 | Call Spread | 30-Oct-2668 : 72 C | 4,032 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
GE HealthCare Advances New PET Imaging Formulation Study
TipRanks (Thu, 5-Nov 11:34 AM ET)
Business Wire (Tue, 3-Nov 9:00 AM ET)
GE Healthcare Earnings Call Signals Strong 2026 Momentum
TipRanks (Mon, 2-Nov 7:16 PM ET)
Business Wire (Sun, 1-Nov 12:35 PM ET)
GE HealthCare reports third quarter 2026 financial results
Business Wire (Wed, 28-Oct 6:20 AM ET)
Business Wire (Tue, 20-Oct 12:39 PM ET)
Business Wire (Mon, 19-Oct 9:00 AM ET)
Business Wire (Fri, 16-Oct 8:47 AM ET)
Business Wire (Thu, 15-Oct 8:00 AM ET)
GE HealthCare to announce third quarter 2026 results on October 28, 2026
Business Wire (Wed, 7-Oct 8:00 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of November 6, 2026, GEHC stock price declined to $82.38 with 3,782,547 million shares trading.
GEHC has a beta of 0.49, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.03 to the broad based SPY ETF.
GEHC has a market cap of $37.21 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $159 million and exceeded earnings estimates by $.13.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VTI, QQQ, VOO, VO, IVV.
GEHC has outperformed the market in the last year with a price return of +11.3% while the SPY ETF gained +10.8%. GEHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.2% and +15.3%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
GEHC support price is $81.85 and resistance is $85.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.
